Dolby Laboratories, Inc. (DLB) DCF Valuation & Fundamental Primer
Dolby Laboratories, Inc. (DLB) currently trades at $63.84 with an enterprise value of $8.53B. Our proprietary institutional model rates Dolby Laboratories, Inc. at 88/100 (Grade: A+ · Elite SaaS Compounder). The current market price prices in an implied 5-year revenue CAGR of 15.4% vs. historical growth of 25.8% (Substantial Margin of Safety).
Institutional fundamental teardown of Dolby Laboratories, Inc. (DLB) covering SEC 10-K/10-Q cash flow conversion, SBC dilution friction, and Reverse-DCF valuation hurdles.
Dolby Laboratories, Inc. (DLB) 3-Scenario DCF Valuation Range
Stress-test DLB's 5-year growth, target FCF margin, WACC, terminal methodology, and SBC/dilution friction in real time.
Split between 5-Year Explicit Cash Flows and Discounted Terminal Value
2D Institutional Valuation Sensitivity Heatmap
Implied share price & upside/downside spread across 25 valuation states (Current Price: $63.84).
| WACC \ Terminal | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 8.5% | $103.30 +62% | $109.77 +72% | $117.32 +84% | $126.25 +98% | $136.96 +115% |
| 9.3% | $92.81 +45% | $97.91 +53% | $103.76 +63% | $110.56 +73% | $118.53 +86% |
| 10.0% | $84.19 +32% | $88.29 +38% | $92.94 +46% | $98.25 +54% | $104.38 +64% |
| 10.8% | $77.00 +21% | $80.35 +26% | $84.11 +32% | $88.35 +38% | $93.18 +46% |
| 11.5% | $70.90 +11% | $73.68 +15% | $76.76 +20% | $80.22 +26% | $84.10 +32% |
Institutional Software Quality Scorecard (88/100 · Grade A+)
Exceptional unit economics, disciplined equity dilution, and fortress balance sheet.
Elite deferred revenue float; FCF exceeds operating income by >20%
Standard software SBC dilution; modest equity transfer to employees
Elite Tier-1 SaaS compounder with high gross margin and superior Rule of 40
Positive net cash cushion; self-funding operations with zero insolvency risk
Core Investment Strengths & Moats
- High-grade cash conversion: FCF is 173% of EBIT driven by upfront annual collections
- Top-quartile software unit economics: 80.9% gross margin and 53.4% Rule of 40 score
- Net cash positive: $377.1M balance sheet buffer
Key Operational & Dilution Risks
Reverse-DCF Solver: What Growth is Priced Into DLB?
The current share price only requires 15.4% 5-year CAGR (24.3% dilution-adjusted), well below historical growth of 25.8%. If the company maintains baseline execution, there is asymmetric upside.
Headline Reverse-DCF ignores Stock-Based Compensation (12.1% of revenue) and annual share dilution (1.8%/yr). Accounting for both requires 24.3% 5-year revenue CAGR to justify $63.84/sh on a true per-share economic cash flow basis.
Dolby Laboratories, Inc. (DLB) 5-Year Fundamental Forecast
| Statement Line Item | TTM Audited Base | TTM | Y1 | Y2 | Y3 | Y4 | Y5 |
|---|---|---|---|---|---|---|---|
| Revenue | $900.0M | $900.0M | $1.13B | $1.42B | $1.79B | $2.25B | $2.84B |
| Gross Profit | $728.1M | $728.1M | $916.0M | $1.15B | $1.45B | $1.82B | $2.29B |
| Operating Income (EBIT) | $144.0M | $144.0M | $181.2M | $227.9M | $286.7M | $360.7M | $453.7M |
| Stock-Based Compensation (SBC) | $108.9M | $108.9M | $137.0M | $172.3M | $216.8M | $272.7M | $343.1M |
| Unlevered Free Cash Flow (FCF) | $248.4M | $248.4M | $312.5M | $393.1M | $494.5M | $622.1M | $782.6M |
| SBC-Adjusted True Cash Flow | $139.5M | $139.5M | $175.5M | $220.8M | $277.7M | $349.4M | $439.5M |
Software & Cloud Services Peer Comparables & Rule of 40 Regression
Rule of 40 vs. EV / Revenue Multiple Regression
OLS Fit: EV/Rev = -28.6 + 0.77 × (Rule of 40) · R² = 62%Stocks below the gold regression line trade at a discount relative to their Rule of 40 compounding efficiency.
| Company | Ticker | Market Cap | TTM Revenue | Gross Margin | FCF Margin | Rule of 40 | SBC % Rev | EV / Rev |
|---|---|---|---|---|---|---|---|---|
| Dolby Laboratories, Inc. | DLB | $6.12B | $900.0M | 80.9% | 27.6% | 53.4% | 12.1% | 6.4× |
| ServiceNow | NOW | $152.61B | $10.98B | 79.2% | 31.1% | 54.2% | 15.9% | 13.9× |
| Workday, Inc. | WDAY | $50.35B | $8.00B | 75.0% | 27.4% | 43.9% | 19.0% | 6.4× |
| Salesforce | CRM | $217.10B | $37.90B | 77.2% | 32.8% | 42.8% | 8.4% | 5.8× |
| Datadog | DDOG | $46.05B | $2.68B | 80.8% | 31.1% | 57.7% | 21.3% | 17.4× |
| Snowflake Inc. | SNOW | $71.79B | $3.63B | 66.5% | 25.2% | 57.7% | 40.8% | 20.0× |
| Hubspot | HUBS | $19.89B | $2.63B | 85.0% | 21.3% | 52.7% | 19.2% | 7.7× |
| Peer Cohort Median Benchmark (N=6) | 78.2% | 29.2% | 53.5% | 19.1% | 10.8× | |||
EV / Revenue Multiple Compression Stress Test
| Multiple Scenario | EV / Revenue | Implied Enterprise Value | Implied Equity Value | Implied Share Price | Delta vs Current |
|---|---|---|---|---|---|
| Current Multiple | 6.4× | $5.74B | $6.12B | $63.84 | 0.0% |
| -20% Multiple Compression | 5.1× | $4.59B | $4.97B | $51.86 | -20.0% |
| -35% Multiple Compression | 4.1× | $3.73B | $4.11B | $42.87 | -35.0% |
| Software Baseline Floor (5.0× EV/Rev) | 5.0× | $4.50B | $4.88B | $50.87 | -21.6% |
Frequently Asked Questions: Dolby Laboratories, Inc. (DLB) Valuation
What is Dolby Laboratories, Inc. (DLB)'s intrinsic DCF valuation and implied share price?
Based on audited SEC 10-K/10-Q filings and a 5-year 3-statement discounted cash flow (DCF) model, Dolby Laboratories, Inc. (DLB) has a Base Case implied value of $92.94 per share (with a Bear Case of $38.60 and a Bull Case of $173.84), compared to its current price of $63.84. The model discounts projected free cash flows at a 10.0% WACC and a 2.5% terminal growth rate.
What is Dolby Laboratories, Inc. (DLB)'s Rule of 40 score and Free Cash Flow margin?
Dolby Laboratories, Inc. achieves a Rule of 40 score of 53.4%, combining a 25.8% revenue growth run-rate with a 27.6% TTM free cash flow margin on $900.0M in trailing twelve-month revenue. In the Software & Cloud Services peer cohort, the median Rule of 40 benchmark is 53.5%.
What revenue growth rate is priced into DLB stock according to Reverse-DCF analysis?
At $63.84 per share (Enterprise Value of $5.74B), our Reverse-DCF solver indicates the market is pricing in a 5-year implied revenue CAGR of 15.4%, compared to Dolby Laboratories, Inc.'s historical CAGR of 25.8%. Overall market expectations are rated as "Substantial Margin of Safety".
How does Dolby Laboratories, Inc. compare to Software & Cloud Services software peers?
Dolby Laboratories, Inc. (DLB) earns an institutional Software Quality Score of 88/100 (Grade A+ — Elite SaaS Compounder). Across its Software & Cloud Services peer group (NOW, WDAY, CRM, DDOG, SNOW), the cohort trades at a median EV/TTM Revenue multiple of 10.8× and a median gross margin of 78.2%.
How does Stock-Based Compensation (SBC) impact Dolby Laboratories, Inc. (DLB)'s valuation?
Dolby Laboratories, Inc. recorded $108.9M in TTM stock-based compensation (12.1% of revenue). When treating SBC as a cash-equivalent compensation expense, Dolby Laboratories, Inc.'s SBC-adjusted free cash flow yield is 2.3%, scoring 16/25 on our Shareholder Dilution Friction pillar.